The 20-year trend of medications prescribed during admission in patient with acute coronary syndrome.

<p>Data are expressed in numbers (%) of patients. Same abbreviations mentioned in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0040571#pone-0040571-t002" target="_blank">table 2</a>.</p

The predictors of in-hospital mortality in patients with prior coronary artery bypass surgery who presented with acute coronary syndrome.

<p>CABG  =  coronary artery bypass graft; ACS  =  acute coronary syndrome; ACE  =  angiotensin-converting enzyme; ARB  =  angiotensin receptor blocker; LMWH  =  low molecular weight heparin.</p

Multivariate analysis of predictors of in-hospital mortality in patients presented with acute coronary syndromes.

<p>CABG  =  coronary artery bypass graft; LMWH  =  low molecular weight heparin; ACE =  angiotension converting enzyme, ARB  =  angiotensin receptor blocker; CI  =  confident interval.</p

The 20 years trend of mortality in 16,750 patients with acute coronary syndrome with or without history of prior coronary artery bypass surgery.

<p>CABG  =  coronary artery bypass graft; ACS  =  acute coronary syndrome.</p

Medication received before, during admission and at discharge in acute coronary syndrome patients with or without prior coronary artery bypass surgery.

<p>Data are expressed in numbers (%) of patients.CABG  =  coronary artery bypass graft; HMG-CoA  =  hydroxy methyl glutaryl-coenzyme A; GP  =  glycoprotein; LMWH  =  low molecular weight heparin; CCB  =  calcium channel blockers; ACE = angiotension converting enzyme inhibitor, ARB = angiotensin receptor blocker.</p

Acute coronary syndrome patients’ baseline demographics, clinical characteristics and outcomes according to their history of prior coronary artery bypass surgery.

<p>Data are expressed in numbers (%) of patients unless otherwise indicated.</p>*<p>Systolic blood pressure >140 mm Hg, diastolic blood pressure >90 mm Hg, or current antihypertensive treatment.</p>†<p>Patient had been informed of the diagnosis by a physician before admission and for type 1 or 2 diabetes.</p>††<p>Total cholesterol >5.2 mmol/L or current use of lipid-lowering agent.</p>‡<p>Of patients eligible for thrombolysis (ST-elevation myocardial infarction (previously known Q wave MI) or new or presumed left bundle branch block).CABG  = coronary artery bypass graft; CCU = coronary care unit; MI = myocardial infarction; STEMI = ST elevation myocardial infarction; NSTEMI = non ST elevation myocardial infarction.</p